Zimmer Biomet Joins India Ortho Parade

Zimmer Biomet Holdings, Inc. has joined Stryker Corporation as a “preferred” orthopedic partner with the Indo UK Institutes of Health (IUIH).

The company’s announcement on November 22, 2016 follows Stryker’s partnership announcement with the IUIH just a week earlier.

Money, Joints, Protocols and Education

Zimmer Biomet’s commitments to the program include:

• an equity investment in UK Global Healthcare Limited (UKGH), the parent organization for IUIH
• the supply and distribution of quality large joint implants, trauma products and small fixation devices for replacement surgery
• the implementation of the Rapid Recovery and Theatre Care Rapide programs to optimize patient-focused processes and protocols in the hospitals and operating rooms across the 11 Medicities
• and the establishment of the Zimmer Biomet Institute of India, a state-of-the-art medical training and education facility.

Stryker’s commitment included the sponsorship of a post-graduate training and education center on the campus of one of IUIH`s Medicities and R&D collaboration with Stryker’s longstanding Global Technology Center in India.

National Health Service (NHS) in India

The IUIH is a collaboration announced November 2015 between the Indian and UK governments and UK’s National Health Service (NHS) to ensure closer cooperation and speedy implementation of healthcare projects in India.

Kings College Hospital is the strategic clinical partner of the first of 11 proposed institutes throughout India to develop high quality hospitals, nursing schools and medical colleges. When fully implemented, the initiative will amount to a £1 billion investment into India’s healthcare system. This will become one of the world’s largest ongoing healthcare projects aimed at adding 11, 000 beds across 11 states in India to serve 400 million people.

Ajay Rajan Gupta, M.D., group CEO of IUIH, noted last November that this project “is all about bringing the ‘best of British’ healthcare to India—‘NHS in India’.” He has worked within the NHS as a consultant orthopedic surgeon for several years and said he has seen first-hand how lucky the UK is to have “such a fantastic service.”

“My ambition is to provide access to this fantastic service to as many of my fellow Indians as possible through the 11 Indo-UK Institutes of Health. I thank [India] Prime Ministers Narender Modi and [former British] David Cameron for their support for this innovative healthcare project in India which will benefit both the NHS and India.”

Dave Dvorak, Zimmer Biomet’s president and CEO said this long-term commitment, “demonstrates an unprecedented level of partnership between a forward-looking healthcare provider and a leading musculoskeletal healthcare company, putting transformational patient care and exponential value creation within reach.”